Close Menu

'Useful Vigilance'

Bloomberg's John Lauerman has a rare JAK2 variant that is associated with cancer-like blood disorders, including myelofibrosis. He also has a APOE-C130R variant that increases his risk of Alzheimer's disease. Despite this, the 53-year-old Personal Genome Project participant says he considers himself fortunate.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.